X-ray crystal structure of human dopamine sulfotransferase, SULT1A3 - Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity

被引:126
作者
Dajani, R
Cleasby, A
Neu, M
Wonacott, AJ
Jhoti, H
Hood, AM
Modi, S
Hersey, A
Taskinen, J
Cooke, RM
Manchee, GR
Coughtrie, MWH [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
[2] Glaxo Wellcome Med Res Ctr, Prot Sci Unit, Stevenage SG1 2NY, Herts, England
[3] Glaxo Wellcome Res & Dev, Res Biomet, Ware SG12 0DP, Herts, England
[4] Univ Helsinki, Viikki Bioctr, Dept Pharm, FIN-00014 Helsinki, Finland
关键词
D O I
10.1074/jbc.274.53.37862
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humans are one of the few species that produce large amounts of catecholamine sulfates, and they have evolved a specific sulfotransferase, SULT1A3 (M-PST), to catalyze the formation of these conjugates. An orthologous protein has yet to be found in other species. To further our understanding of the molecular basis for the unique substrate selectivity of this enzyme, we have solved the crystal structure of human SULT1A3, complexed with 3'-phosphoadenosine 5'-phosphate (PAP), at 2.5 Angstrom resolution and carried out quantitative structure-activity relationship (QSAR) analysis with a series of phenols and catechols. SULT1A3 adopts a similar fold to mouse estrogen sulfotransferase, with a central five-stranded beta-sheet surrounded by alpha-helices. SULT1A3 is a dimer in solution but crystallized with a monomer in the asymmetric unit of the cell, although dimer interfaces were formed by interaction across crystallographic 2-fold axes. QSAR analysis revealed that the enzyme is highly selective for catechols, and catecholamines in particular, and that hydrogen bonding groups and lipophilicity (cLogD) strongly influenced K-m. We also investigated further the role of Glu(146) in SULT1A3 using site-directed mutagenesis and showed that it plays a key role not only in defining selectivity for dopamine but also in preventing many phenolic xenobiotics fi om binding to the enzyme.
引用
收藏
页码:37862 / 37868
页数:7
相关论文
共 26 条
  • [1] Structural characterization of human aryl sulphotransferases
    Brix, LA
    Duggleby, RG
    Gaedigk, A
    McManus, ME
    [J]. BIOCHEMICAL JOURNAL, 1999, 337 : 337 - 343
  • [2] BRONAUGH RL, 1975, J PHARMACOL EXP THER, V195, P441
  • [3] CAMPBELL NRC, 1987, MOL PHARMACOL, V32, P813
  • [4] Sulphation catalysed by the human cytosolic sulphotransferases - Chemical defence or molecular terrorism?
    Coughtrie, MWH
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1996, 15 (07) : 547 - 555
  • [5] Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases
    Coughtrie, MWH
    Sharp, S
    Maxwell, K
    Innes, NP
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1998, 109 (1-3) : 3 - 27
  • [6] A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3
    Dajani, R
    Hood, AM
    Coughtrie, MWH
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (06) : 942 - 948
  • [7] Kinetic properties of human dopamine sulfotransferase (SULT1A3) expressed in prokaryotic and eukaryotic systems:: Comparison with the recombinant enzyme purified from Escherichia coli
    Dajani, R
    Sharp, S
    Graham, S
    Bethell, SS
    Cooke, RM
    Jamieson, DJ
    Coughtrie, MWH
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 1999, 16 (01) : 11 - 18
  • [8] DOUSA MK, 1988, P SOC EXP BIOL MED, V188, P427
  • [9] DUFFEL MW, 1997, COMPREHENSIVE TOXICO, V3, P365
  • [10] Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells
    Eaton, EA
    Walle, UK
    Wilson, HM
    Aberg, G
    Walle, T
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (03) : 201 - 206